Jennifer R. Brown, MD, PhD, Clinical Strategies for Selecting Treatment in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Posted: Thursday, April 1, 2021

Jennifer R. Brown, MD, PhD, of Dana-Farber Cancer Institute, discusses the latest data on selecting treatment for patients with relapsed or refractory CLL/SLL, the factors to consider, and recommendations on following those with minimal residual disease.